Prior authorization is, by most measures, the single most frustrating process in modern healthcare billing. I’ve watched physicians abandon treatments, patients delay surgeries, and billing teams spend entire days on phone queues — all because an insurer required advance approval before care could proceed.
In 2026, this burden has grown significantly worse. And AI is accelerating it on both sides.
What Is Prior Authorization and Why Is It a Billing Problem?
Prior authorization is a payer requirement that providers obtain approval before delivering certain services, medications, or procedures — and it creates billing problems because delays, denials, and administrative errors directly prevent or defer revenue collection.
In the AMA’s 2025 nationwide survey of 1,000 practicing physicians, 95% reported that prior authorization delays access to necessary care, and 79% reported that it can lead patients to abandon treatment entirely — the practice loses the visit, the procedure, and the relationship.
What Does Prior Authorization Cost the Health System — and Your Practice?
Prior authorization is estimated to account for roughly $35 billion of U.S. health-care administrative spending each year. That is a system-wide figure, not a per-practice one — it does not divide neatly into an annual cost per physician.
What a practice can measure is volume: in the AMA’s 2025 survey, physicians reported completing an average of 39 prior authorization requests per week. This is time that generates no revenue, treats no patients, and produces nothing except a payer response that may still come back denied. To check whether a specific CPT code usually needs prior authorization before you schedule it, use the free PA Check CPT lookup.
Why Are Prior Authorization Denials Increasing in 2026?
Prior authorization denials are increasing because payers are expanding the list of services requiring approval, deploying AI to review requests faster with less clinical context, and tightening medical necessity criteria that automated systems apply rigidly without judgment.
In the AMA’s 2025 survey, 60% of physicians said health plans’ use of AI increases, or will increase, prior authorization denial rates. Multiple lawsuits allege that major insurers are issuing batch denials through automated systems with no meaningful clinical review — violating CMS requirements.
What Services Are Most Commonly Subject to Prior Authorization?
The most commonly prior-authorized services in 2026 include specialty medications (particularly GLP-1s and biologics), advanced imaging, elective surgical procedures, physical and behavioral therapy, and home health services.
For specialty practices — orthopedics, oncology, rheumatology, and psychiatry — prior authorization touches the majority of high-value services. Biologic therapy carries high stakes: in a large managed-care claims study of rheumatoid arthritis patients, average first-year biologic costs ranged from about $14,800 to $19,500 per patient depending on the agent. A single authorization can gate that entire course of care.
How Can Practices Reduce Prior Authorization Burden and Denials?
Practices reduce prior authorization burden most effectively through electronic prior authorization (ePA) technology, proactive submission before scheduling, documentation templates aligned to payer criteria, and dedicated PA staff or outsourced authorization services.
Electronic prior authorization is the most impactful single intervention. ePA systems submit requests, track status, and receive approvals through direct payer integrations — eliminating phone queues entirely for participating payers. CMS expanded ePA mandates for Medicare Advantage plans in 2026.
Proactive submission matters equally. Scheduling a procedure without confirming authorization status first is one of the most common and expensive PA errors. The service is performed. The auth wasn’t obtained. The claim is denied. The appeal is complex. Revenue is delayed by months.
What Happens When a Prior Authorization Is Denied?
When a prior authorization is denied, the provider can submit a peer-to-peer review request, file a formal appeal with supporting clinical documentation, or — for Medicare Advantage patients — appeal to the plan. In 2024, Medicare Advantage insurers overturned 80.7% of the prior authorization denials that were appealed, but only 11.5% of denials were ever appealed at all.
Peer-to-peer reviews are dramatically underused. They allow the treating physician to speak directly with the payer’s medical reviewer — often resulting in immediate reversal if the case is presented with clinical specificity. Many denials that appear final are overturned within 24–48 hours.
Are There New 2026 Regulations That Help Providers on Prior Authorization?
Yes — CMS finalized rules requiring Medicare Advantage, Medicaid, and exchange plans to implement electronic prior authorization APIs, reduce PA decision timeframes, and provide specific denial reasons — all taking effect for most plans in 2026.
The final rule also requires payers to publicly report PA approval and denial rates by service category — creating accountability that didn’t previously exist and giving providers data to identify which payers deny most aggressively for specific services.
Frequently Asked Questions
Q: Can a patient receive care while a prior authorization appeal is pending?
A: It depends on the payer and the service. For urgent care, services can often proceed and authorization sought retroactively. For elective procedures, most payers require authorization before service delivery.
Q: What is a Gold Carding exception and how does it help?
A: Gold Carding exempts high-performing physicians from prior authorization requirements for services they consistently receive approval for. Several states enacted Gold Carding laws in 2024–2025.
Q: How long is a prior authorization typically valid?
A: PA validity varies by payer and service, and there is no universal window. For Medicare Advantage plans, CMS requires an approved authorization for a course of treatment to remain valid for as long as the treatment is medically reasonable and necessary, and a new plan must give enrollees already in treatment at least 90 days before requiring its own authorization. Expired authorizations on still-pending procedures are a common source of denials. Tracking PA expiration dates is essential.
Sources: American Medical Association, 2025 Prior Authorization Physician Survey (survey statistics); Health Affairs Scholar (2024) ($35 billion administrative-spending estimate); CMS Prior Authorization Final Rule (CMS-0057-F) (regulatory content); InvicieQ Billing Challenges 2026 (general prior-authorization burden)
Leave a Reply